Ambroxol AL 75 Retard capsules

Ambroxol AL 75 Retard is a pharmaceutical product used for the treatment of respiratory diseases with viscous mucus. The brand 'AL' stands for Aliud Pharma, which has its roots in Germany. Aliud Pharma was founded in 1986 as a subsidiary to provide high-quality generic medications at affordable prices. It quickly became a significant player in the German pharmaceutical market.

Today, Aliud Pharma is a subsidiary of STADA Arzneimittel AG, a major international pharmaceutical company based in Bad Vilbel, Germany. Manufacturing primarily takes place in Germany under strict EU pharmaceutical standards, though the ultimate parent company STADA utilizes a global supply chain to maintain production efficiency. STADA itself is currently owned by private equity firms Bain Capital and Cinven, positioning the brand within a global portfolio of healthcare assets.